Patents Represented by Attorney George S. Jones
  • Patent number: 7202059
    Abstract: Fusion protein including a fusion part and a protein of interest, the combination of the two proteins leading to the fusion protein being secreted into a supernatant of a bacterial host with the protein of interest being present in its correct three-dimensional structure. Nucleic acid including a sequence coding for a fusion protein, the sequence including: —F—Asm—Rn—Y—, where F is a nucleic acid sequence coding for an amino acid sequence which allows secretion of a protein encoded by Y into a fermentation medium, As is a chemical bond or a nucleic acid sequence comprising a codon, m is an integer from 0–10, R is a chemical bond or an arginine codon, n is 0 or 1, and Y is a nucleic acid sequence coding for a protein of interest. Processes therefor.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: April 10, 2007
    Assignees: Sanofi-Aventis Deutschland GmbH, Wacker-Chemie GmbH
    Inventors: Paul Habermann, Johann Ertl
  • Patent number: 7179631
    Abstract: Human and murine analogs of DUBs, hematopoietic-specific, cytokine-inducible deubiquitinating proteases, clustered on chromosome 7 and and their respective regulatory regions are identified. The nucleotide or proteins encoded thereby may be used in assays to identify inhibitors of hDUB7, human deubiquitinating enzyme, or mDUB7, mouse deubiquitinating enzyme. The invention also includes transducing peptides comprising an NLS, nuclear localization signal, or transducing sequence of hDUB7 or mDUB7 linked to a cargo molecule, and methods of delivering a biologically active protein, therapeutically effective compound, antisense nucleotide, or test compound to a cell wherein a transducing peptide is added exogenously to a cell.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: February 20, 2007
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Chang S. Hahn, Hong Liu